Astec Lifesciences Quarterly Results for Trading Insights

ASTEC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-24 Cr
QSept 2025
Quarterly Results

Astec Lifesciences Quarterly Results Key Highlights

  • Revenue of ₹75 Cr in Sept 2025 (-37.5% vs Mar 2025, -25.7% vs Sept 2024)
  • Net Profit of ₹-24 Cr in Sept 2025 (-50.0% vs Mar 2025, +38.5% vs Sept 2024)
  • EBITDA of ₹-6 Cr in Sept 2025 (-200.0% vs Mar 2025)
  • Operating Margin of -9.0% in Sept 2025 (-14.0pp vs Mar 2025)
  • Earnings Per Share of ₹-11.35 in Sept 2025 (-38.4% vs Mar 2025)

Astec Lifesciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 75 120 92 101 156 -37.5% -25.7%
Net Profit (₹ Cr) -24 -16 -33 -39 -1 - -
EBITDA (₹ Cr) -6 6 -11 -18 15 - -
EPS (₹) -11.35 -8.20 -16.85 -19.66 -0.50 - -
Operating Margin (%) -9.0% 5.0% -12.0% -20.0% 8.0% - -

Astec Lifesciences Share Price Trend Around Quarterly Results

Visualize Astec Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Astec Lifesciences share price chart using Tickjournal. All values in ₹.

Related Pages for Astec Lifesciences

Additional stock information and data for ASTEC

ASTEC fair value
Astec Lifesciences shareholding analysis
ASTEC value investing
Astec Lifesciences market cap
ASTEC share price charts
Astec Lifesciences annual reports
ASTEC price book multiple

Profitability Ratios

Profit Margin -32.0%
EBITDA Margin -8.0%
Operating Margin -9.0%
ROE (Annual) -40.9%

Balance Sheet Highlights

Total Assets ₹881 Cr
Total Equity ₹235 Cr
Current Assets ₹341 Cr
Current Liabilities ₹281 Cr

Cash Flow Analysis

Operating Cash Flow ₹-8 Cr
Investing Cash Flow ₹-15 Cr
Financing Cash Flow ₹24 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹593.25
Exchange NSE
Last Updated Feb 03, 2026

Revenue Trend (₹ Cr)

Sept 2024 101
Jun 2025 92
Mar 2025 120
Sept 2025 75

Net Profit Trend (₹ Cr)

Sept 2024 -39
Jun 2025 -33
Mar 2025 -16
Sept 2025 -24

Operating Margin Trend (%)

Sept 2024 -20.0%
Jun 2025 -12.0%
Mar 2025 5.0%
Sept 2025 -9.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Astec Lifesciences quarterly results with other companies in Chemicals sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Sept 2025 		₹145,818.07 Cr 1427.8 3,605 585 +11.9% - 16.2% 250.9
SRF
Sept 2025 		₹81,098.87 Cr 2912.2 3,560 388 -16.2% - 10.9% 222.3
Coromandel Internat…
Sept 2025 		₹66,312.02 Cr 2292.2 9,771 793 +78.9% - 8.1% 83.8
UPL
Sept 2025 		₹59,074.48 Cr 739.8 12,411 612 -20.8% - 4.9% 109.6
Linde
Sept 2025 		₹52,185.42 Cr 6003.5 650 171 +7.4% - 26.3% 299.4
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores